RS52453B - Modulation of prostaglandin/cyclooxygenase metabolic pathways - Google Patents

Modulation of prostaglandin/cyclooxygenase metabolic pathways

Info

Publication number
RS52453B
RS52453B RS20120372A RSP20120372A RS52453B RS 52453 B RS52453 B RS 52453B RS 20120372 A RS20120372 A RS 20120372A RS P20120372 A RSP20120372 A RS P20120372A RS 52453 B RS52453 B RS 52453B
Authority
RS
Serbia
Prior art keywords
group
prostaglandin
modulation
metabolic pathways
hydrogen atom
Prior art date
Application number
RS20120372A
Other languages
Serbian (sr)
Inventor
Ernst WĂśLFERT
Original Assignee
Hunter-Fleming Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter-Fleming Limited filed Critical Hunter-Fleming Limited
Priority claimed from PCT/GB2007/004584 external-priority patent/WO2008065408A2/en
Publication of RS52453B publication Critical patent/RS52453B/en

Links

Abstract

Korišćenje jedinjenja formule (II):u kojoj:R1 predstavlja atom vodonika ili metil grupu; iR2, R3 i R4 su isti ili se razlikuju jedan od drugog, a svaki predstavlja: okso grupu, hidroksi grupu, merkapto grupu, atom vodonika, atom halogena, alkoksi grupu, ariloksi grupu ili acil grupu;ili njegove farmaceutski prihvatljive soli ili estra,za proizvodnju leka za lečenje ili profilaksu inflamatornih bolesti disajnih puteva.Prijava sadrži još 3 patentna zahteva.Use of a compound of formula (II): wherein: R 1 represents a hydrogen atom or a methyl group; and R 2, R 3 and R 4 are the same or different from each other, each representing: oxo group, hydroxy group, mercapto group, hydrogen atom, halogen atom, alkoxy group, aryloxy group or acyl group, or pharmaceutically acceptable salts or esters thereof, for the manufacture of a medicament for the treatment or prophylaxis of inflammatory respiratory diseases. The application contains 3 more patent claims.

RS20120372A 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways RS52453B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86787306P 2006-11-30 2006-11-30
GB0623971A GB0623971D0 (en) 2006-11-30 2006-11-30 Modulation of prostaglandin/cyclooxygenase metabolic pathways
PCT/GB2007/004584 WO2008065408A2 (en) 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways

Publications (1)

Publication Number Publication Date
RS52453B true RS52453B (en) 2013-02-28

Family

ID=37671641

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20120372A RS52453B (en) 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways

Country Status (9)

Country Link
CN (1) CN101594861B (en)
DK (1) DK2097079T3 (en)
ES (1) ES2390182T3 (en)
GB (1) GB0623971D0 (en)
NZ (1) NZ577075A (en)
PT (1) PT2097079E (en)
RS (1) RS52453B (en)
RU (1) RU2448712C2 (en)
SI (1) SI2097079T1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI713972B (en) * 2019-01-14 2020-12-21 大江生醫股份有限公司 The improving respiratory health probiotic strain, composition thereof and use thereof
TWI692359B (en) * 2019-02-25 2020-05-01 大江生醫股份有限公司 Metabolite of lactic acid bacteria and use of the metabolite of lactic acid bacteria for protecting lungs
CN111777613A (en) * 2019-04-03 2020-10-16 中国药科大学 Preparation and application of pyrimidinedione indole and pyridone indole compounds
CN113905732A (en) * 2019-04-09 2022-01-07 纽罗比特科学有限公司 Pharmaceutical composition for preventing or treating spinal cord injury or spinal stenosis
CN111394289B (en) * 2019-12-20 2021-06-11 合肥康诺生物制药有限公司 Genetically engineered bacterium and application thereof, and method for producing prostaglandin E2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363984A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
FR2829697B1 (en) * 2001-09-14 2004-03-19 Mayoly Spindler Lab 7-HYDROXYL AND 7-KETONIC DERIVATIVES OF 3-HYDROXYLATED STEROID HORMONES FOR THE TREATMENT OF INFLAMMATORY OR FUNCTIONAL INTESTINAL DISEASES

Also Published As

Publication number Publication date
PT2097079E (en) 2012-09-24
RU2009124917A (en) 2011-01-10
ES2390182T3 (en) 2012-11-07
RU2448712C2 (en) 2012-04-27
GB0623971D0 (en) 2007-01-10
DK2097079T3 (en) 2012-10-01
CN101594861B (en) 2013-06-12
SI2097079T1 (en) 2012-10-30
NZ577075A (en) 2012-01-12
CN101594861A (en) 2009-12-02

Similar Documents

Publication Publication Date Title
RS52435B (en) Proteasome inhibitors
RS51805B (en) Fungicidal compositions
TW200833675A (en) Nicotinamide derivatives
RS51280B (en) Novel hydantoin derivatives for the treatment of obstructive airway diseases
ATE444066T1 (en) LIGANDS FOR THE CANNABINOID RECEPTORS
HRP20060254A2 (en) Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
BR112014003237A2 (en) indazole compounds, compositions and methods of use
MX2010002820A (en) Thiazolidinedione analogues for the treatment of hypertension.
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
EA200870193A1 (en) CYTOTOXIC AGENTS, INCLUDING NEW TOMAMYCIN DERIVATIVES, AND THEIR THERAPEUTIC APPLICATION
ECSP066383A (en) DERIVATIVES OF 5-PHENYL-4-METHYL-TIAZOL-2-IL-AMINA AS INHIBITORS OF KINASA ENZYMES PHOSFATIDILINOSITOL 3 (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY ROUTES
NZ591728A (en) Cephalosporin having catechol group
RS52245B (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
ECSP088717A (en) AMINA DERIVATIVES
IL198226A0 (en) 2-[l-phenyl-5-hydroxy-4alpha-methyl
EA200802213A1 (en) METHODS OF TREATING BLOOD DISEASES
ATE537175T1 (en) NEW PIPERAZINO-DIHYDROTHIENOPYRIMIDINE DERIVATIVES
RS54260B1 (en) Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
MX2010004232A (en) Pyrimidyl indoline compound.
UA95766C2 (en) Terphenyl derivatives for the treatment of alzheimer' s disease
GEP20125389B (en) Substituted pyrazole and triazole compounds as ksp inhibitors
DE502005009091D1 (en) NEW 2-SUBSTITUTED D-HOMO ESTRA-1,3,5 (10) DRIVES AS INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE TYPE 1
MX2009013885A (en) Fused quinoline derivatives useful as gaba modulators.
RS52453B (en) Modulation of prostaglandin/cyclooxygenase metabolic pathways